Skip to main content
Mark Pennesi, MD, Ophthalmology, Portland, OR

MarkEdwardPennesiMDPhD

Ophthalmology Portland, OR

Retinal Disease

Ophthalmic Genetics

Dr. Pennesi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pennesi's full profile

Already have an account?

  • Office

    3375 SW Terwilliger Blvd
    Cei
    Portland, OR 97239
    Phone+1 503-494-8386

Education & Training

  • University of Pennsylvania
    University of PennsylvaniaBS, Bioengineering, Summa Cum Laude, 1997
  • Oregon Health  Science University Hospital
    Oregon Health Science University HospitalFellowship, Ophthalmic Genetics and Inherited Retinal Degeneration, 2008 - 2009
  • University of California
    University of California2005 - 2008
  • Scripps Mercy Hospital
    Scripps Mercy Hospital2005 - 2005
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2004
  • Baylor College of Medicine
    Baylor College of MedicinePh.D, Neuroscience, 2003 - 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - Present
  • TX State Medical License
    TX State Medical License 2023 - 2026
  • OR State Medical License
    OR State Medical License 2008 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Scientist Research Award ARVO/Alcon Early Clinician, 2011
  • Travel Award International Society for Clinical Electrophysiology in Vision, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Strategies for Treating Inherited Retinal Degeneration with Large Genes That Are Not Amenable to Adeno-Associated Virus–Based Gene Replacement Therapy  
    Mark E Pennesi, Richard G Weleber, JAMA Ophthalmology
  • Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug Cessation  
    Joseph M Simonett, Mark E Pennesi, Nieraj Jain, JAMA Ophthalmology
  • Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis Pigmentosa  
    David G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Lentiviral Vector for Gene Replacement Therapy in Stargardt Disease and Usher Syndrome Type IB.
    Wilson D, Stout JT, Weleber RG, Pennesi ME, Francis PJ, Sahel J, Mohand-Said S, Naylor S Audo I, Macula Society, Jerusalem Israel
  • Imaging the Cone Mosaic using a Commerically available Adaptive Optics Flood Illuminated Camera and Examining its Potential as an Endpoint for Clinical Trials.
    Pennesi ME, Fay JD, Faridi A, Garg AK, Chegarnov EN, Michaels KV, International Society for Clinical Electrophysiology in Vision, Valencia, Spain
  • Hand-Held Spectral-Domain Optical Coherence Tomography in the Evaluation of Patients in a Pediatric Ophthalmic Genetics Clinic.
    Pennesi ME, Courtney RJ, Francis PJ, Weleber RG, International Society for Clinical Electrophysiology in Vision, Quebec City, Montreal
  • Join now to see all

Lectures

  • SD-OCT of Mice and Men. 
    Coordes Conference, UCSF
  • Retinitis Pigmentosa. 
    Foundation Fighting Blindness, Visions Conference
  • The Advantages of Hand-held sdOCT for Studying Retinal Degeneration in Infants and Animal Models. 
    National Eye Institute
  • Join now to see all

Authored Content

  • Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
  • Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
  • Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020

Press Mentions

  • CRISPR Can Treat Common Form of Inherited Blindness, Early Data Hint
    CRISPR Can Treat Common Form of Inherited Blindness, Early Data HintMay 15th, 2024
  • Gene Therapy Improves Vision in Leber Congenital Amaurosis Patients
    Gene Therapy Improves Vision in Leber Congenital Amaurosis PatientsMay 10th, 2024
  • CRIPSR Gene Editing Leads to Improvements in Vision for People with Inherited Blindness, Clinical Trial Shows
    CRIPSR Gene Editing Leads to Improvements in Vision for People with Inherited Blindness, Clinical Trial ShowsMay 6th, 2024
  • Join now to see all

Grant Support

  • Serotonin Receptor Modulation Of Neurotrophic Factors In The RetinaNational Eye Institute2011–2012

Professional Memberships